New Fox Chase Attending Physician Focuses on Leukemia and Lymphoma
PHILADELPHIA (September, 2008) — Adam Cohen, MD, has joined Fox Chase Cancer Center's medical oncology staff as an attending physician. He treats patients with cancers of the blood and bone marrow such as leukemia and lymphoma.
Cohen has a special interest in the cancer called multiple myeloma and a rare related disorder called amyloidosis, which occurs when bone marrow produces too much of certain antibody proteins that then build up in the bloodstream and may affect various organs.
"My goal is to develop new therapies for these complicated diseases, with a focus on trying to harness the power of the immune system to attack and hopefully eliminate cancerous cells," Cohen says.
A board-certified medical oncologist, Cohen earned his MD at the University of Pennsylvania. He comes to Fox Chase from Memorial Sloan-Kettering Cancer Center in New York, where he completed a fellowship in 2005.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.